Regenxbio (RGNX) Operating Leases (2019 - 2026)
Regenxbio (RGNX) posted quarterly Operating Leases of $65.2 million for Q4 2025, down 12.03% year-over-year from $74.1 million in Q4 2024, and down 3.29% quarter-over-quarter from $67.4 million in Q3 2025.
Regenxbio (RGNX) Operating Leases (2019 - 2026) Analysis & Trends
Regenxbio's Operating Leases history runs 7 years deep, the most recent figure standing at $65.2 million for Q4 2025.
- In Q4 2025, Operating Leases fell 12.03% year-over-year to $65.2 million; the TTM figure through Dec 2025 stood at $65.2 million (down 12.03% YoY), while the FY2025 annual figure was $65.2 million, down 12.03% from the prior year.
- Operating Leases for Q4 2025 stood at $65.2 million, down from $67.4 million in the prior quarter.
- The five-year high for Operating Leases was $88.8 million in Q4 2022, with the low at $65.2 million in Q4 2025.
- The 5-year median for Operating Leases is $82.3 million (2021), against an average of $79.6 million.
- The sharpest annual moves came in 2021 and 2025: Operating Leases soared 1062.78% in 2021, then decreased 12.03% in 2025.
- Regenxbio's Operating Leases stood at $84.9 million in 2021, then climbed by 4.56% to $88.8 million in 2022, then declined by 7.41% to $82.2 million in 2023, then decreased by 9.84% to $74.1 million in 2024, then retreated by 12.03% to $65.2 million in 2025.
- Business Quant data shows RGNX's Operating Leases at $65.2 million in Q4 2025, $67.4 million in Q3 2025, and $69.6 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Regenxbio | 583.35 Mn | 477.83 Mn | 106.98 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 61.60 Mn |
| Dec 31, 2025 | 65.22 Mn |
| Sep 30, 2025 | 67.43 Mn |
| Jun 30, 2025 | 69.65 Mn |
| Mar 31, 2025 | 71.91 Mn |
| Dec 31, 2024 | 74.13 Mn |
| Sep 30, 2024 | 76.34 Mn |
| Jun 30, 2024 | 78.23 Mn |
| Mar 31, 2024 | 80.18 Mn |
| Dec 31, 2023 | 82.22 Mn |
| Sep 30, 2023 | 84.06 Mn |
| Jun 30, 2023 | 85.25 Mn |
| Mar 31, 2023 | 86.99 Mn |
| Dec 31, 2022 | 88.80 Mn |
| Sep 30, 2022 | 84.67 Mn |
| Jun 30, 2022 | 85.67 Mn |
| Mar 31, 2022 | 85.57 Mn |
| Dec 31, 2021 | 84.93 Mn |
| Sep 30, 2021 | 83.88 Mn |
| Jun 30, 2021 | 82.38 Mn |